Clinical-stage biopharmaceutical firm ARCA Biopharma (NASDAQ:ABIO) — which develops and commercializes cardiovascular disease therapies — saw its shares skyrocket during the midweek session.

Oruka Therapeutics, Inc. (NASDAQ:ORKA – Get Free Report) shares saw an uptick in trading volume on Tuesday . 133,137 shares traded hands during mid-day trading, an increase of 43% from the previous ...

Popular Brokers : Popular Brokers Arca biopharma is a clinical-stage biopharmaceutical company that specializes in developing targeted therapies for cardiovascular diseases. The stock jumped in ...

Earn $+0.06 per options contract and 5.1% APY on cash with no restrictions. Arca biopharma is a clinical-stage biopharmaceutical company that specializes in developing targeted therapies for ...